Skip to content
777 Sourcing.

Capability

rare disease treatment development

Suppliers
1
States & provinces
1
Countries
1

1 rare disease treatment development supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

ITF THERAPEUTICS LLC

CONCORD, MA

ITF Therapeutics LLC is the United States rare disease affiliate of Italfarmaco S.p.A., established in January 2024 with headquarters in Concord, MA, to develop and commercialize rare disease treatments in the United States. It secured FDA approval for its first product within six months of launch and reached well over a thousand US patients with commercial supply by its first anniversary.

commercializationpatient advocacy and engagement

Compiled from public sources

Related capabilities

Other processes offered by the shops that list rare disease treatment development.

Browse all capabilities